SKLB-197 is a potent and highly selective inhibitor of ataxia telangiectasia and Rad3-related kinase (ATR) with an IC50 value of 0.013 µM and minimal activity against more than 402 other kinases. SKLB-197 shows strong antitumor efficacy in ATM-deficient tumors both in vitro and in vivo, while also exhibiting favorable pharmacokinetic properties for oncology research.
Molecular Weight:
424.5
Purity:
99.53%
CAS Number:
[2713577-16-1]
Formula:
C25H24N6O
Target:
ATM/ATR
T62290
T62290
* VAT and and shipping costs not included. Errors and price changes excepted